Action Madrigal Pharmaceuticals - MDGL

Madrigal Pharmaceuticals Inc (MDGL) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

488,15

( 7,79% )

Prix Achat

452,00

Prix Vente

487,95

Volume échangé

264 548

445,20 Fourchette du Jour 490,12

268,69 Plage de 52 semaines 615,00

Cap du marché

11,255B

Clôture Veille

452,86

Ouverture

450,61

Dernière Transaction

487

Dernière heure de transaction

Volume financier

US$ 124 593 881

VWAP

470,9689

Volume moyen (3 m)

US$ 313 742

Actions en circulation

23 055 659

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-37,8

Bénéfice par action (BPA)

-13,65

Chiffre d'affairess (LTM)

1,13B

Bénéfice net (LTM)

-309,44M

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was found... Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania. Show more

Secteur

Healthcare

Industrie

Biotechnology & Life Sciences

Site Web

www.madrigalpharma.com

Siège social

West Conshohocken, United States

Fondé

2026

Madrigal Pharmaceuticals Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker MDGL. Le dernier cours de clôture d'Madrigal Pharmaceuticals était de US$452,86. Au cours de la dernière année, les actions de Madrigal Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 268,69 à US$ 615,00.

Madrigal Pharmaceuticals compte actuellement 23 055 659 actions en circulation. La capitalisation boursière d'Madrigal Pharmaceuticals est de US$11,25 milliard. Madrigal Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -37.80.

Flux global

Haussier

Prime nette

1M

Calls / Puts

550,00%

Ach. / Vent.

225,00%

OTM / ITM

30,00%

Sweeps Ratio

0,00%

Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026

CONSHOHOCKEN, Pa., June 03, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today...

Form 4 - Statement of changes in beneficial ownership of securities

Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH

Growing body of clinical and real-world evidence supports the role of Rezdiffra® (resmetirom) as the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

CONSHOHOCKEN, Pa., May 21, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a...

Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk

Secondary analysis from the Phase 3 MAESTRO-NASH and MAESTRO-NAFLD-1 trials examines improvements in lipid...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-36.15	-6.89490749571	524.3	535.76	451.74	295770	487.85592503	CS
4	-43.05	-8.10429216867	531.2	559	451.74	312890	513.16758625	CS
12	60.2	14.0670639093	427.95	572.195	421.55	316866	504.75269322	CS
26	-91.52	-15.7882933393	579.67	615	416.21	331380	504.17953911	CS
52	216.16	79.4735100555	271.99	615	268.69	347113	448.99218264	CS
156	228.15	87.75	260	615	119.7604	387421	307.34257426	CS
260	383.22	365.214905175	104.93	615	52.33	341252	260.01380883	CS

MDGL - Frequently Asked Questions (FAQ)

What is the current Madrigal Pharmaceuticals Inc share price?

The current share price of Madrigal Pharmaceuticals Inc is US$ 488,15

How many Madrigal Pharmaceuticals Inc shares are in issue?

Madrigal Pharmaceuticals Inc has 23 055 659 shares in issue

What is the market cap of Madrigal Pharmaceuticals Inc?

The market capitalisation of Madrigal Pharmaceuticals Inc is USD 11,25B

What is the 1 year trading range for Madrigal Pharmaceuticals Inc share price?

Madrigal Pharmaceuticals Inc has traded in the range of US$ 268,69 to US$ 615,00 during the past year

What is the PE ratio of Madrigal Pharmaceuticals Inc?

The price to earnings ratio of Madrigal Pharmaceuticals Inc is -37,8

What is the cash to sales ratio of Madrigal Pharmaceuticals Inc?

The cash to sales ratio of Madrigal Pharmaceuticals Inc is 10,5

What is the registered address of Madrigal Pharmaceuticals Inc?

The registered address for Madrigal Pharmaceuticals Inc is Four Tower Bridge, West Conshohocken, Pennsylvania, 19428

What is the Madrigal Pharmaceuticals Inc website address?

The website address for Madrigal Pharmaceuticals Inc is www.madrigalpharma.com

Which industry sector does Madrigal Pharmaceuticals Inc operate in?

Madrigal Pharmaceuticals Inc operates in the Biotechnology & Life Sciences sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc (MDGL) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Madrigal Pharmaceuticals Inc

Flux d'options Madrigal Pharmaceuticals (MDGL)

Flux global

Haussier

Prime nette

1M

Calls / Puts

550,00%

Ach. / Vent.

225,00%

OTM / ITM

30,00%

Sweeps Ratio

0,00%

MDGL Dernières nouvelles

Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026

Form 4 - Statement of changes in beneficial ownership of securities

Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026

Form 4 - Statement of changes in beneficial ownership of securities

Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal’s (MDGL) MASH Strategy Reiinforced By Rezdiffra Sales Growth and Pipeline Expansion

MDGL - Frequently Asked Questions (FAQ)

MDGL Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités